nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroxyaluminium—VDAC2—connective tissue—rheumatoid arthritis	0.0357	0.0919	CbGeAlD
Dihydroxyaluminium—VDAC3—parotid gland—rheumatoid arthritis	0.0338	0.087	CbGeAlD
Dihydroxyaluminium—VDAC3—saliva-secreting gland—rheumatoid arthritis	0.0324	0.0833	CbGeAlD
Dihydroxyaluminium—VDAC1—parotid gland—rheumatoid arthritis	0.0322	0.0828	CbGeAlD
Dihydroxyaluminium—VDAC1—saliva-secreting gland—rheumatoid arthritis	0.0308	0.0793	CbGeAlD
Dihydroxyaluminium—Acidosis—Ergocalciferol—rheumatoid arthritis	0.0298	0.0625	CcSEcCtD
Dihydroxyaluminium—VDAC1—connective tissue—rheumatoid arthritis	0.0283	0.0728	CbGeAlD
Dihydroxyaluminium—VDAC2—lymphoid tissue—rheumatoid arthritis	0.0261	0.0672	CbGeAlD
Dihydroxyaluminium—VDAC2—digestive system—rheumatoid arthritis	0.0258	0.0664	CbGeAlD
Dihydroxyaluminium—TNNC1—connective tissue—rheumatoid arthritis	0.0243	0.0624	CbGeAlD
Dihydroxyaluminium—VDAC1—Mitochondrial protein import—SLC25A12—rheumatoid arthritis	0.0242	0.233	CbGpPWpGaD
Dihydroxyaluminium—VDAC3—digestive system—rheumatoid arthritis	0.0215	0.0553	CbGeAlD
Dihydroxyaluminium—VDAC1—lymphoid tissue—rheumatoid arthritis	0.0207	0.0533	CbGeAlD
Dihydroxyaluminium—VDAC3—tendon—rheumatoid arthritis	0.0205	0.0526	CbGeAlD
Dihydroxyaluminium—VDAC1—digestive system—rheumatoid arthritis	0.0204	0.0526	CbGeAlD
Dihydroxyaluminium—VDAC1—tendon—rheumatoid arthritis	0.0195	0.0501	CbGeAlD
Dihydroxyaluminium—TNNC1—tendon—rheumatoid arthritis	0.0167	0.0429	CbGeAlD
Dihydroxyaluminium—Toxicity to various agents—Cyclosporine—rheumatoid arthritis	0.0165	0.0346	CcSEcCtD
Dihydroxyaluminium—VDAC1—Mitochondrial protein import—HSPD1—rheumatoid arthritis	0.0156	0.15	CbGpPWpGaD
Dihydroxyaluminium—Blindness transient—Methotrexate—rheumatoid arthritis	0.0143	0.0299	CcSEcCtD
Dihydroxyaluminium—Extravasation—Penicillamine—rheumatoid arthritis	0.0142	0.0299	CcSEcCtD
Dihydroxyaluminium—Polyuria—Ergocalciferol—rheumatoid arthritis	0.0136	0.0286	CcSEcCtD
Dihydroxyaluminium—TNNC1—MFAP5-mediated ovarian cancer cell motility and invasiveness—PRKCQ—rheumatoid arthritis	0.0127	0.122	CbGpPWpGaD
Dihydroxyaluminium—TNNC1—MFAP5-mediated ovarian cancer cell motility and invasiveness—PTK2—rheumatoid arthritis	0.0108	0.104	CbGpPWpGaD
Dihydroxyaluminium—Thrombophlebitis—Penicillamine—rheumatoid arthritis	0.0104	0.0219	CcSEcCtD
Dihydroxyaluminium—Electrolyte imbalance—Hydrocortisone—rheumatoid arthritis	0.01	0.021	CcSEcCtD
Dihydroxyaluminium—Electrolyte imbalance—Methylprednisolone—rheumatoid arthritis	0.00943	0.0198	CcSEcCtD
Dihydroxyaluminium—TNNC1—Muscle contraction—CALD1—rheumatoid arthritis	0.00884	0.0851	CbGpPWpGaD
Dihydroxyaluminium—Electrolyte imbalance—Betamethasone—rheumatoid arthritis	0.00857	0.018	CcSEcCtD
Dihydroxyaluminium—Electrolyte imbalance—Dexamethasone—rheumatoid arthritis	0.00857	0.018	CcSEcCtD
Dihydroxyaluminium—Encephalopathy—Cyclosporine—rheumatoid arthritis	0.00735	0.0154	CcSEcCtD
Dihydroxyaluminium—Cardiovascular disorder—Leflunomide—rheumatoid arthritis	0.00695	0.0146	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Auranofin—rheumatoid arthritis	0.00651	0.0137	CcSEcCtD
Dihydroxyaluminium—VDAC1—Fluocinolone Acetonide—Methylprednisolone—rheumatoid arthritis	0.00561	0.183	CbGdCrCtD
Dihydroxyaluminium—VDAC1—Fluocinolone Acetonide—Betamethasone—rheumatoid arthritis	0.00552	0.18	CbGdCrCtD
Dihydroxyaluminium—VDAC1—Fluocinolone Acetonide—Dexamethasone—rheumatoid arthritis	0.00552	0.18	CbGdCrCtD
Dihydroxyaluminium—VDAC1—Fluocinolone Acetonide—Triamcinolone—rheumatoid arthritis	0.00539	0.176	CbGdCrCtD
Dihydroxyaluminium—Cardiovascular disorder—Cyclosporine—rheumatoid arthritis	0.00537	0.0113	CcSEcCtD
Dihydroxyaluminium—Pain—Ergocalciferol—rheumatoid arthritis	0.00504	0.0106	CcSEcCtD
Dihydroxyaluminium—VDAC1—Fluocinolone Acetonide—Prednisolone—rheumatoid arthritis	0.005	0.163	CbGdCrCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—EDEM3—rheumatoid arthritis	0.00432	0.0416	CbGpPWpGaD
Dihydroxyaluminium—Coma—Cyclosporine—rheumatoid arthritis	0.00431	0.00903	CcSEcCtD
Dihydroxyaluminium—Extravasation—Betamethasone—rheumatoid arthritis	0.0041	0.0086	CcSEcCtD
Dihydroxyaluminium—Extravasation—Dexamethasone—rheumatoid arthritis	0.0041	0.0086	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—ST6GALNAC5—rheumatoid arthritis	0.00406	0.0392	CbGpPWpGaD
Dihydroxyaluminium—Encephalopathy—Methotrexate—rheumatoid arthritis	0.00406	0.00851	CcSEcCtD
Dihydroxyaluminium—Polyuria—Cyclosporine—rheumatoid arthritis	0.0039	0.00817	CcSEcCtD
Dihydroxyaluminium—Urticaria—Auranofin—rheumatoid arthritis	0.00381	0.008	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Leflunomide—rheumatoid arthritis	0.00373	0.00783	CcSEcCtD
Dihydroxyaluminium—Lung disorder—Methotrexate—rheumatoid arthritis	0.00368	0.00772	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—SYVN1—rheumatoid arthritis	0.00368	0.0354	CbGpPWpGaD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—KIF5A—rheumatoid arthritis	0.00368	0.0354	CbGpPWpGaD
Dihydroxyaluminium—Visual disturbance—Cyclosporine—rheumatoid arthritis	0.00361	0.00757	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Prednisolone—rheumatoid arthritis	0.0036	0.00754	CcSEcCtD
Dihydroxyaluminium—VDAC1—Levonorgestrel—Hydrocortisone—rheumatoid arthritis	0.00359	0.117	CbGdCrCtD
Dihydroxyaluminium—Urticaria—Penicillamine—rheumatoid arthritis	0.00352	0.00739	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Hydrocortisone—rheumatoid arthritis	0.00351	0.00737	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Penicillamine—rheumatoid arthritis	0.00351	0.00735	CcSEcCtD
Dihydroxyaluminium—Nausea—Ergocalciferol—rheumatoid arthritis	0.0035	0.00733	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Triamcinolone—rheumatoid arthritis	0.00331	0.00694	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Methylprednisolone—rheumatoid arthritis	0.0033	0.00692	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Prednisolone—rheumatoid arthritis	0.00329	0.00689	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Auranofin—rheumatoid arthritis	0.00329	0.00689	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Penicillamine—rheumatoid arthritis	0.00327	0.00685	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—SLC25A12—rheumatoid arthritis	0.00308	0.0297	CbGpPWpGaD
Dihydroxyaluminium—Rhinitis—Leflunomide—rheumatoid arthritis	0.00308	0.00645	CcSEcCtD
Dihydroxyaluminium—Vomiting—Auranofin—rheumatoid arthritis	0.00305	0.0064	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Penicillamine—rheumatoid arthritis	0.00303	0.00636	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Dexamethasone—rheumatoid arthritis	0.003	0.00629	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Betamethasone—rheumatoid arthritis	0.003	0.00629	CcSEcCtD
Dihydroxyaluminium—Extravasation—Methotrexate—rheumatoid arthritis	0.00299	0.00626	CcSEcCtD
Dihydroxyaluminium—Chills—Azathioprine—rheumatoid arthritis	0.00292	0.00611	CcSEcCtD
Dihydroxyaluminium—Nausea—Auranofin—rheumatoid arthritis	0.00285	0.00598	CcSEcCtD
Dihydroxyaluminium—Vomiting—Penicillamine—rheumatoid arthritis	0.00282	0.00591	CcSEcCtD
Dihydroxyaluminium—Chills—Leflunomide—rheumatoid arthritis	0.00275	0.00577	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Betamethasone—rheumatoid arthritis	0.00274	0.00575	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Dexamethasone—rheumatoid arthritis	0.00274	0.00575	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—DPP4—rheumatoid arthritis	0.00267	0.0257	CbGpPWpGaD
Dihydroxyaluminium—Nausea—Penicillamine—rheumatoid arthritis	0.00263	0.00552	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Prednisone—rheumatoid arthritis	0.00261	0.00548	CcSEcCtD
Dihydroxyaluminium—Back pain—Leflunomide—rheumatoid arthritis	0.00258	0.00542	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Leflunomide—rheumatoid arthritis	0.00252	0.00528	CcSEcCtD
Dihydroxyaluminium—Vertigo—Leflunomide—rheumatoid arthritis	0.0024	0.00503	CcSEcCtD
Dihydroxyaluminium—Coma—Methotrexate—rheumatoid arthritis	0.00238	0.00499	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Cyclosporine—rheumatoid arthritis	0.00237	0.00498	CcSEcCtD
Dihydroxyaluminium—Infection—Azathioprine—rheumatoid arthritis	0.00229	0.00481	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Cyclosporine—rheumatoid arthritis	0.00228	0.00478	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—B3GNT2—rheumatoid arthritis	0.00227	0.0219	CbGpPWpGaD
Dihydroxyaluminium—Thrombophlebitis—Methotrexate—rheumatoid arthritis	0.00219	0.00458	CcSEcCtD
Dihydroxyaluminium—Infection—Leflunomide—rheumatoid arthritis	0.00217	0.00454	CcSEcCtD
Dihydroxyaluminium—Hypotension—Azathioprine—rheumatoid arthritis	0.00216	0.00452	CcSEcCtD
Dihydroxyaluminium—Polyuria—Methotrexate—rheumatoid arthritis	0.00215	0.00452	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Leflunomide—rheumatoid arthritis	0.00213	0.00446	CcSEcCtD
Dihydroxyaluminium—Chills—Cyclosporine—rheumatoid arthritis	0.00212	0.00445	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Prednisolone—rheumatoid arthritis	0.00208	0.00435	CcSEcCtD
Dihydroxyaluminium—Hypotension—Leflunomide—rheumatoid arthritis	0.00204	0.00427	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Methotrexate—rheumatoid arthritis	0.002	0.00419	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Triamcinolone—rheumatoid arthritis	0.00199	0.00417	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—HSPD1—rheumatoid arthritis	0.00198	0.0191	CbGpPWpGaD
Dihydroxyaluminium—Rhinitis—Methylprednisolone—rheumatoid arthritis	0.00198	0.00416	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Cyclosporine—rheumatoid arthritis	0.00194	0.00407	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Methylprednisolone—rheumatoid arthritis	0.00191	0.00399	CcSEcCtD
Dihydroxyaluminium—Pain—Leflunomide—rheumatoid arthritis	0.00186	0.00391	CcSEcCtD
Dihydroxyaluminium—Vertigo—Cyclosporine—rheumatoid arthritis	0.00185	0.00388	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Azathioprine—rheumatoid arthritis	0.00182	0.00383	CcSEcCtD
Dihydroxyaluminium—Convulsion—Cyclosporine—rheumatoid arthritis	0.00179	0.00374	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Prednisolone—rheumatoid arthritis	0.00177	0.00371	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Dexamethasone—rheumatoid arthritis	0.00173	0.00363	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Betamethasone—rheumatoid arthritis	0.00173	0.00363	CcSEcCtD
Dihydroxyaluminium—Urticaria—Leflunomide—rheumatoid arthritis	0.00173	0.00363	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Leflunomide—rheumatoid arthritis	0.00172	0.00361	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Azathioprine—rheumatoid arthritis	0.0017	0.00357	CcSEcCtD
Dihydroxyaluminium—Vertigo—Prednisolone—rheumatoid arthritis	0.00169	0.00353	CcSEcCtD
Dihydroxyaluminium—Oedema—Cyclosporine—rheumatoid arthritis	0.00168	0.00353	CcSEcCtD
Dihydroxyaluminium—Infection—Cyclosporine—rheumatoid arthritis	0.00167	0.0035	CcSEcCtD
Dihydroxyaluminium—Back pain—Triamcinolone—rheumatoid arthritis	0.00167	0.0035	CcSEcCtD
Dihydroxyaluminium—Vertigo—Hydrocortisone—rheumatoid arthritis	0.00165	0.00345	CcSEcCtD
Dihydroxyaluminium—Convulsion—Prednisolone—rheumatoid arthritis	0.00163	0.00341	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.00161	0.00337	CcSEcCtD
Dihydroxyaluminium—Convulsion—Hydrocortisone—rheumatoid arthritis	0.00159	0.00333	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Azathioprine—rheumatoid arthritis	0.00158	0.00331	CcSEcCtD
Dihydroxyaluminium—Vertigo—Triamcinolone—rheumatoid arthritis	0.00155	0.00325	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—CTSD—rheumatoid arthritis	0.00155	0.0149	CbGpPWpGaD
Dihydroxyaluminium—Vertigo—Methylprednisolone—rheumatoid arthritis	0.00155	0.00324	CcSEcCtD
Dihydroxyaluminium—Oedema—Prednisolone—rheumatoid arthritis	0.00153	0.00321	CcSEcCtD
Dihydroxyaluminium—Dizziness—Azathioprine—rheumatoid arthritis	0.00153	0.0032	CcSEcCtD
Dihydroxyaluminium—Oedema—Hydrocortisone—rheumatoid arthritis	0.0015	0.00313	CcSEcCtD
Dihydroxyaluminium—Convulsion—Triamcinolone—rheumatoid arthritis	0.00149	0.00313	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Prednisolone—rheumatoid arthritis	0.00149	0.00313	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Leflunomide—rheumatoid arthritis	0.00149	0.00313	CcSEcCtD
Dihydroxyaluminium—Convulsion—Methylprednisolone—rheumatoid arthritis	0.00149	0.00313	CcSEcCtD
Dihydroxyaluminium—Infection—Hydrocortisone—rheumatoid arthritis	0.00149	0.00311	CcSEcCtD
Dihydroxyaluminium—Vomiting—Azathioprine—rheumatoid arthritis	0.00147	0.00308	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Hydrocortisone—rheumatoid arthritis	0.00146	0.00306	CcSEcCtD
Dihydroxyaluminium—Dizziness—Leflunomide—rheumatoid arthritis	0.00144	0.00302	CcSEcCtD
Dihydroxyaluminium—Pain—Cyclosporine—rheumatoid arthritis	0.00144	0.00302	CcSEcCtD
Dihydroxyaluminium—Oedema—Triamcinolone—rheumatoid arthritis	0.00141	0.00295	CcSEcCtD
Dihydroxyaluminium—Vertigo—Betamethasone—rheumatoid arthritis	0.00141	0.00295	CcSEcCtD
Dihydroxyaluminium—Vertigo—Dexamethasone—rheumatoid arthritis	0.00141	0.00295	CcSEcCtD
Dihydroxyaluminium—Infection—Triamcinolone—rheumatoid arthritis	0.0014	0.00293	CcSEcCtD
Dihydroxyaluminium—Hypotension—Hydrocortisone—rheumatoid arthritis	0.0014	0.00293	CcSEcCtD
Dihydroxyaluminium—Infection—Methylprednisolone—rheumatoid arthritis	0.0014	0.00293	CcSEcCtD
Dihydroxyaluminium—Vomiting—Leflunomide—rheumatoid arthritis	0.00139	0.00291	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Triamcinolone—rheumatoid arthritis	0.00137	0.00288	CcSEcCtD
Dihydroxyaluminium—Nausea—Azathioprine—rheumatoid arthritis	0.00137	0.00287	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.00137	0.00287	CcSEcCtD
Dihydroxyaluminium—Convulsion—Betamethasone—rheumatoid arthritis	0.00136	0.00284	CcSEcCtD
Dihydroxyaluminium—Convulsion—Dexamethasone—rheumatoid arthritis	0.00136	0.00284	CcSEcCtD
Dihydroxyaluminium—Urticaria—Cyclosporine—rheumatoid arthritis	0.00134	0.0028	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.00133	0.00279	CcSEcCtD
Dihydroxyaluminium—Hypotension—Methylprednisolone—rheumatoid arthritis	0.00131	0.00275	CcSEcCtD
Dihydroxyaluminium—Pain—Prednisolone—rheumatoid arthritis	0.00131	0.00274	CcSEcCtD
Dihydroxyaluminium—Nausea—Leflunomide—rheumatoid arthritis	0.00129	0.00271	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Prednisone—rheumatoid arthritis	0.00128	0.00269	CcSEcCtD
Dihydroxyaluminium—Pain—Hydrocortisone—rheumatoid arthritis	0.00128	0.00268	CcSEcCtD
Dihydroxyaluminium—Oedema—Dexamethasone—rheumatoid arthritis	0.00128	0.00268	CcSEcCtD
Dihydroxyaluminium—Oedema—Betamethasone—rheumatoid arthritis	0.00128	0.00268	CcSEcCtD
Dihydroxyaluminium—Infection—Betamethasone—rheumatoid arthritis	0.00127	0.00266	CcSEcCtD
Dihydroxyaluminium—Infection—Dexamethasone—rheumatoid arthritis	0.00127	0.00266	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Methotrexate—rheumatoid arthritis	0.00126	0.00264	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Betamethasone—rheumatoid arthritis	0.00125	0.00261	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Dexamethasone—rheumatoid arthritis	0.00125	0.00261	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.00124	0.0026	CcSEcCtD
Dihydroxyaluminium—Vertigo—Prednisone—rheumatoid arthritis	0.00122	0.00257	CcSEcCtD
Dihydroxyaluminium—Urticaria—Prednisolone—rheumatoid arthritis	0.00122	0.00255	CcSEcCtD
Dihydroxyaluminium—Pain—Triamcinolone—rheumatoid arthritis	0.0012	0.00252	CcSEcCtD
Dihydroxyaluminium—Hypotension—Dexamethasone—rheumatoid arthritis	0.00119	0.0025	CcSEcCtD
Dihydroxyaluminium—Hypotension—Betamethasone—rheumatoid arthritis	0.00119	0.0025	CcSEcCtD
Dihydroxyaluminium—Urticaria—Hydrocortisone—rheumatoid arthritis	0.00119	0.00249	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.00118	0.00248	CcSEcCtD
Dihydroxyaluminium—Convulsion—Prednisone—rheumatoid arthritis	0.00118	0.00248	CcSEcCtD
Dihydroxyaluminium—Chills—Methotrexate—rheumatoid arthritis	0.00117	0.00246	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.00115	0.00241	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.00113	0.00236	CcSEcCtD
Dihydroxyaluminium—Urticaria—Triamcinolone—rheumatoid arthritis	0.00112	0.00234	CcSEcCtD
Dihydroxyaluminium—Urticaria—Methylprednisolone—rheumatoid arthritis	0.00112	0.00234	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.00111	0.00233	CcSEcCtD
Dihydroxyaluminium—Dizziness—Cyclosporine—rheumatoid arthritis	0.00111	0.00233	CcSEcCtD
Dihydroxyaluminium—Oedema—Prednisone—rheumatoid arthritis	0.00111	0.00233	CcSEcCtD
Dihydroxyaluminium—Infection—Prednisone—rheumatoid arthritis	0.00111	0.00232	CcSEcCtD
Dihydroxyaluminium—Back pain—Methotrexate—rheumatoid arthritis	0.0011	0.00231	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.0011	0.00231	CcSEcCtD
Dihydroxyaluminium—Pain—Dexamethasone—rheumatoid arthritis	0.00109	0.00229	CcSEcCtD
Dihydroxyaluminium—Pain—Betamethasone—rheumatoid arthritis	0.00109	0.00229	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Prednisone—rheumatoid arthritis	0.00109	0.00228	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Methotrexate—rheumatoid arthritis	0.00107	0.00225	CcSEcCtD
Dihydroxyaluminium—Vomiting—Cyclosporine—rheumatoid arthritis	0.00107	0.00224	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.00104	0.00217	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.00104	0.00217	CcSEcCtD
Dihydroxyaluminium—Vertigo—Methotrexate—rheumatoid arthritis	0.00102	0.00215	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.00102	0.00214	CcSEcCtD
Dihydroxyaluminium—Urticaria—Betamethasone—rheumatoid arthritis	0.00101	0.00213	CcSEcCtD
Dihydroxyaluminium—Urticaria—Dexamethasone—rheumatoid arthritis	0.00101	0.00213	CcSEcCtD
Dihydroxyaluminium—Dizziness—Prednisolone—rheumatoid arthritis	0.00101	0.00212	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.00101	0.00212	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Betamethasone—rheumatoid arthritis	0.00101	0.00212	CcSEcCtD
Dihydroxyaluminium—Nausea—Cyclosporine—rheumatoid arthritis	0.000999	0.0021	CcSEcCtD
Dihydroxyaluminium—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000989	0.00207	CcSEcCtD
Dihydroxyaluminium—Convulsion—Methotrexate—rheumatoid arthritis	0.000987	0.00207	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000961	0.00202	CcSEcCtD
Dihydroxyaluminium—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000951	0.00199	CcSEcCtD
Dihydroxyaluminium—Dizziness—Triamcinolone—rheumatoid arthritis	0.000931	0.00195	CcSEcCtD
Dihydroxyaluminium—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000929	0.00195	CcSEcCtD
Dihydroxyaluminium—Infection—Methotrexate—rheumatoid arthritis	0.000924	0.00194	CcSEcCtD
Dihydroxyaluminium—Nausea—Prednisolone—rheumatoid arthritis	0.000909	0.00191	CcSEcCtD
Dihydroxyaluminium—Vomiting—Triamcinolone—rheumatoid arthritis	0.000895	0.00188	CcSEcCtD
Dihydroxyaluminium—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000893	0.00187	CcSEcCtD
Dihydroxyaluminium—Nausea—Hydrocortisone—rheumatoid arthritis	0.000888	0.00186	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—MMP1—rheumatoid arthritis	0.000887	0.00854	CbGpPWpGaD
Dihydroxyaluminium—Urticaria—Prednisone—rheumatoid arthritis	0.000884	0.00185	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Prednisone—rheumatoid arthritis	0.000879	0.00184	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000874	0.00183	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000874	0.00183	CcSEcCtD
Dihydroxyaluminium—Hypotension—Methotrexate—rheumatoid arthritis	0.000869	0.00182	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—LEP—rheumatoid arthritis	0.000858	0.00826	CbGpPWpGaD
Dihydroxyaluminium—Dizziness—Dexamethasone—rheumatoid arthritis	0.000845	0.00177	CcSEcCtD
Dihydroxyaluminium—Dizziness—Betamethasone—rheumatoid arthritis	0.000845	0.00177	CcSEcCtD
Dihydroxyaluminium—Nausea—Triamcinolone—rheumatoid arthritis	0.000836	0.00175	CcSEcCtD
Dihydroxyaluminium—Nausea—Methylprednisolone—rheumatoid arthritis	0.000834	0.00175	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Prednisone—rheumatoid arthritis	0.00082	0.00172	CcSEcCtD
Dihydroxyaluminium—Vomiting—Betamethasone—rheumatoid arthritis	0.000812	0.0017	CcSEcCtD
Dihydroxyaluminium—Vomiting—Dexamethasone—rheumatoid arthritis	0.000812	0.0017	CcSEcCtD
Dihydroxyaluminium—Pain—Methotrexate—rheumatoid arthritis	0.000795	0.00167	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Prednisone—rheumatoid arthritis	0.000761	0.0016	CcSEcCtD
Dihydroxyaluminium—Nausea—Dexamethasone—rheumatoid arthritis	0.000759	0.00159	CcSEcCtD
Dihydroxyaluminium—Nausea—Betamethasone—rheumatoid arthritis	0.000759	0.00159	CcSEcCtD
Dihydroxyaluminium—Urticaria—Methotrexate—rheumatoid arthritis	0.000739	0.00155	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—POMC—rheumatoid arthritis	0.000737	0.0071	CbGpPWpGaD
Dihydroxyaluminium—Dizziness—Prednisone—rheumatoid arthritis	0.000736	0.00154	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Methotrexate—rheumatoid arthritis	0.000735	0.00154	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—CCL2—rheumatoid arthritis	0.000721	0.00695	CbGpPWpGaD
Dihydroxyaluminium—Vomiting—Prednisone—rheumatoid arthritis	0.000707	0.00148	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—MMP2—rheumatoid arthritis	0.000686	0.00661	CbGpPWpGaD
Dihydroxyaluminium—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.000685	0.00144	CcSEcCtD
Dihydroxyaluminium—Nausea—Prednisone—rheumatoid arthritis	0.000661	0.00139	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000636	0.00133	CcSEcCtD
Dihydroxyaluminium—Dizziness—Methotrexate—rheumatoid arthritis	0.000615	0.00129	CcSEcCtD
Dihydroxyaluminium—Vomiting—Methotrexate—rheumatoid arthritis	0.000591	0.00124	CcSEcCtD
Dihydroxyaluminium—VDAC1—Metabolism of proteins—CXCL8—rheumatoid arthritis	0.00057	0.00549	CbGpPWpGaD
Dihydroxyaluminium—Nausea—Methotrexate—rheumatoid arthritis	0.000552	0.00116	CcSEcCtD
